Skip to main content
Equibles
USNA logo

USNA · Usana Health Sciences Inc · Metrics

Track USNA — free

Use USNA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research USNA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$15.12 -0.08 (-0.53%) At close · Sep 9
Russell 2000 member Rebalance outlook locked
Market Cap
$279.37M
Shares
18.48M

USNA metrics

81 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$15.12
Market cap
$279.37M

Price action

20 metrics
Price change (1W)
+8.9%
Price change (30D)
+6.0%
Price change (3M)
-20.0%
Price change (6M)
-14.8%
Price change (YTD)
-22.6%
Price change (1Y)
-50.9%
Trailing year
Price change (5Y)
-84.7%
52-week high
$30.93
52-week low
$12.86
Change from 52-week high
-50.9%
Change from 52-week low
+18.2%
Annualized volatility
57.9%
Annualized volatility (3M)
81.8%
Beta
1.2
RSI (14D)
48.1
Price vs SMA 50
-16.4%
Price vs SMA 200
-20.4%
Avg volume (3M)
166,499
Relative volume
1.5
Average dollar volume
$2.81M

Company

3 metrics
Sector
Consumer Defensive
Industry
Packaged Foods
Shares outstanding
18.48M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.3×
reciprocal yield 330.4%
P / book
0.5
reciprocal yield 190.4%
FCF yield
5.8%
TTM · current market cap
Buyback yield
0.0%
P / FCF
17.3
reciprocal yield 5.8%
P / operating cash flow
10.0
reciprocal yield 10.0%
Earnings yield
-8.0%

Historical valuation

8 metrics
P / E historical average (3Y)
16.1×
reciprocal yield 6.2%
P / E historical average (5Y)
15.7×
reciprocal yield 6.4%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
77.4%
Operating margin
-0.1%
Trailing 12 months
Net margin
-2.4%
Gross profit (TTM)
$707.36M
Operating profit (TTM)
−$1.08M
Net income (TTM)
−$22.16M
Trailing 12 months
Diluted EPS (TTM)
$-1.18
FCF margin
1.7%
Effective tax rate
1,253.4%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$29.16

Growth

11 metrics
Revenue growth YoY
-5.3%
Year over year
Net income growth YoY
-321.5%
Revenue (TTM)
$913.36M
Trailing 12 months
EPS growth YoY
-323.1%
Shares change YoY
-0.3%
Year over year · fewer shares
Revenue CAGR (3Y)
-2.5%
Revenue CAGR (5Y)
-4.0%
EPS CAGR (3Y)
-45.5%
EPS CAGR (5Y)
-37.0%
FCF CAGR (3Y)
-55.0%
FCF CAGR (5Y)
-43.3%

Quality

14 metrics
Return on equity
-4.2%
Return on assets
-3.2%
Debt / equity
—
Current ratio
2.7
EBITDA (TTM)
$31.35M
Free cash flow (TTM)
$15.93M
Quick ratio
1.8
Interest coverage
-2.6
Net debt / EBITDA
-5.4
Return on invested capital
—
Trailing 12 months
Net cash
$168.56M
Latest balance sheet
Cash & equivalents
$168.56M
Total assets
$703.21M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$27.73M
Capital expenditures (TTM)
$11.79M
R&D (TTM)
—
SG&A (TTM)
$334.60M
Stock compensation (TTM)
$14.18M
R&D / revenue
—
Stock compensation / revenue
1.6%

Ownership (13F)

3 metrics
13F filers
137
13F filer change QoQ
-2
Institutional ownership
61.8%

Short interest

3 metrics
Short interest
4.1%
Latest settlement · 2.4 days to cover
Days to cover
2.4d
Short-squeeze score
48 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$147,769
Insider-sentiment score
44 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 896264 CUSIP 90328M107 13F (30d) 89 filings 89 filers Visit website Investor relations